NN Group N.V. (AMS:NN)

Verve Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 4, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	15,499	11,525	9,791	11,257	14,709	11,735
Market Cap Growth	17.71%	17.71%	-13.03%	-23.47%	25.34%	4.68%
Enterprise Value	20,413	17,025	16,690	18,861	19,082	11,072
PE Ratio	10.40	7.60	8.73	7.14	4.57	6.36
PS Ratio	1.23	0.91	0.74	1.32	0.77	0.63
PB Ratio	0.72	0.53	0.46	0.53	0.42	0.30
P/FCF Ratio	-	-	157.91	-	-	1.69
P/OCF Ratio	-	-	157.91	-	-	1.68
EV/Sales Ratio	1.62	1.35	1.27	2.22	1.00	0.59
EV/EBITDA Ratio	4.47	3.76	3.71	23.79	5.48	3.47
EV/EBIT Ratio	4.59	3.83	3.77	25.98	5.58	3.54
EV/FCF Ratio	-	-	269.19	-	-	1.59
Debt / Equity Ratio	0.54	0.54	0.67	0.73	0.35	0.31
Debt / EBITDA Ratio	2.57	2.57	3.10	18.42	3.46	3.68
Debt / FCF Ratio	-	-	227.42	-	-	1.72
Quick Ratio	10.89	10.89	7.99	2.69	0.29	0.45
Current Ratio	12.18	12.18	9.03	3.20	0.75	1.03
Asset Turnover	0.06	0.06	0.06	0.04	0.07	0.07
Return on Equity (ROE)	7.49%	7.49%	5.61%	1.93%	8.58%	5.06%
Return on Assets (ROA)	1.33%	1.33%	1.33%	0.20%	0.83%	0.76%
Return on Capital (ROIC)	8.11%	8.11%	7.72%	1.08%	4.37%	4.08%
Earnings Yield	9.79%	13.74%	11.97%	14.52%	22.29%	16.23%
Earnings Yield	9.79%	13.74%	11.97%	14.52%	22.29%	16.23%
FCF Yield	-	-3.48%	0.63%	-72.12%	-17.95%	59.25%
Dividend Yield	5.93%	8.51%	10.05%	8.93%	6.76%	14.34%
Payout Ratio	48.26%	48.26%	42.49%	30.05%	14.95%	24.79%
Buyback Yield / Dilution	2.02%	2.02%	6.16%	4.40%	1.69%	4.96%
Total Shareholder Return	7.94%	10.53%	16.21%	13.33%	8.45%	19.30%

Updated Mar 12, 2025. Source: S&P Global Market Intelligence. Insurance template. Financial Sources.